2011
DOI: 10.1089/thy.2010.2101.ed
|View full text |Cite
|
Sign up to set email alerts
|

Copy Number Variation in Common Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
3
0

Year Published

2011
2011
2015
2015

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 28 publications
1
3
0
Order By: Relevance
“…As there have been no studies demonstrating improved outcome in treating IH during pregnancy, I do not begin levothyroxine in this group of women. This is consistent with the American Thyroid Association Guidelines, which do not recommend levothyroxine for IH of pregnancy ( 14 ). However, both the Endocrine Society Guidelines and the European Thyroid Association Guidelines state that levothyroxine intervention can be considered, especially for IH diagnosed in the first trimester ( 15 , 25 ).…”
Section: Isolated Hypothyroxinemia Of Pregnancysupporting
confidence: 88%
See 1 more Smart Citation
“…As there have been no studies demonstrating improved outcome in treating IH during pregnancy, I do not begin levothyroxine in this group of women. This is consistent with the American Thyroid Association Guidelines, which do not recommend levothyroxine for IH of pregnancy ( 14 ). However, both the Endocrine Society Guidelines and the European Thyroid Association Guidelines state that levothyroxine intervention can be considered, especially for IH diagnosed in the first trimester ( 15 , 25 ).…”
Section: Isolated Hypothyroxinemia Of Pregnancysupporting
confidence: 88%
“…Nevertheless, most professional societies do not recommend universal thyroid screening during pregnancy due to the limited and mixed results of studies prospectively evaluating the impact of levothyroxine treatment of subclinical hypothyroidism during pregnancy on maternal and fetal outcomes ( 12 , 13 ). It is therefore not surprising that in 2011, the American Thyroid Association guidelines stated that, “There is insufficient evidence to recommend for or against universal TSH screening at the first trimester visit” ( 14 ), whereas the 2012 Endocrine Society Guidelines stated that, “The committee could not reach agreement with regard to screening recommendations for all newly pregnant women” ( 15 ). Similarly, the American College of Obstetricians and Gynecologists does not recommend universal screening ( 16 ).…”
mentioning
confidence: 99%
“…Hemodynamic changes in thyroid hormone act on the circulatory system, leading to decreased peripheral resistance, increased heart rate, myocardial contractility and systolic blood pressure, thereby causing increased pulse pressure and greatly increased cardiac output [ 9 , 10 ]. Volzke et al .…”
Section: Discussionmentioning
confidence: 99%
“…This suggests CNVs are unlikely to have utility in future screens for susceptibility loci in complex genetic diseases. However, fine-mapping studies require interrogation of all polymorphisms, including CNVs to identify an aetiological variant, and therefore, interrogation of CNVs in susceptibility regions is important [107]. The first CNV analysis in GD, recently investigated CNVs in the AITD risk regions, CTLA-4 , CD40 and PTPN22 in 191 GD cases and 192 controls however no association of CNVs within these regions were identified [108].…”
Section: Copy Number Variations and Future Direction In Genetic Studiesmentioning
confidence: 99%